Biomedical Engineering Reference
In-Depth Information
645. Shitara Y, Sato H, Sugiyama Y. 2005. Evaluation of drug-drug interaction in the
hepatobiliary and renal transport of drugs. Annu Rev Pharmacol Toxicol 45: 689-723.
646. Wang JS, Neuvonen M, Wen X, Backman JT, Neuvonen PJ. 2002. Gemfibrozil inhibits
CYP2C8-mediated cerivastatin metabolism in human liver microsomes. Drug Metab
Dispos 30: 1352-1356.
647. Moysey JO, Jaggarao NSV, Grundy EN, Chamberlain DA. 1981. Amiodarone increases
plasma digoxin concentration. Br Med J 282: 272.
648. Nademanee K, Kannan R, Hendrickson J, Ookhtens M, Kay I, Singh BN. 1984.
Amiodarone-digoxin interaction: clinical significance, time course of development,
potential pharmacokinetic mechanisms and therapeutic implications. J Am Coll Cardiol
4: 111-116.
649. Oetgen WJ, Sobol SM, Tri TB, Heydorn WH, Rakita L. 1984. Amiodarone-digoxin
interaction. Clinical and experimental observations. Chest 86: 75-79.
650. Robinson K, Johnston A, Walker S, Mulrow JP, McKenna WJ, Holt DW. 1989. The
digoxin-amiodarone interaction. Cardiovasc Drugs Ther 3: 25-28. Abstract only.
651. Braunschweig J, Staubli M, Studer H. 1987. Interactions of amiodarone with digoxin in
rats. Br J Pharmacol 92: 553-559.
652. Abe T, Unno M, Onogawa T, Tokui T, Kondo TN, Nagakomi R, Adachi H, Fujiwara K,
Okabe M, Suzuki T, et al. 2001. LST-2, a human liver-specific organic anion transporter,
determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology 120:
1689-1699.
653. Lambert C, Lamontage D, Hottlet H, Souich PD. 1989. Amiodarone-digoxin interaction
in rats. A reduction in hepatic uptake. Drug Metab Dispos 17: 704-708.
654. Banfield C, Gupta S, Marino M, Lim J, Affrime M. 2002. Grapefruit juice reduces the oral
bioavailability of fexofenadine but not desloratadine. Clin Pharmacokinet 41: 311-318.
655. Thompson TN, Klaassen CD. 1995. The effects of hepatic microsomal enzyme inducers
on the pharmacokinetics of ouabain after portal and systemic administration to rats.
J Pharm Pharmacol 47: 1041-1047.
656. Pedersoli WM, Ganjam VK, Nachreiner RF. 1980. Serum digoxin concentrations in
dogs before, during, and after concomitant treatment with phenobarbital. Am J Vet Res
41: 1639-1642.
657. Eckhardt U, Horz JA, Petzinger E, Stuber W, Reers M, Dickneite G, Daniel H, Wagener
M, Hagenbuch B, Stieger B, Meier PJ. 1996. The peptide-based thrombin inhibitor CRC
220 is a new substrate of the basolateral rat liver organic anion-transporting polypeptide.
Hepatology 24: 380-384.
658. Fischer WJ, Altheimer S, Cattori V, Meier PJ, Dietrich DR, Hagenbuch B. 2005.
Organic anion-transporting polypeptides expressed in liver and brain mediate uptake of
microcystin. Toxicol Appl Pharmacol 203: 257-263.
659. Shu Y, Leabman MK, Feng B, Mangravite LM, Huang CC, Stryke D, Kawamoto M,
Johns SJ, DeYoung J, Carlson E, et al. 2003. Evolutionary conservation predicts function
of variants of the human organic cation transporter, OCT1. Proc Natl Acad Sci U S A
100: 5902-5907.
660. Saito S, Lida A, Sekine A, Ogawa C, Kawauchi S, Higuchi S, Nakamura Y. 2002.
Catalog of 238 variations among six human genes encoding solute carriers (hSLCs) in
the Japanese population. J Hum Genet 47: 576-584.
Search WWH ::
Custom Search